Stockholm3 test for men on active surveillance in Switzerland
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if a blood test called Stockholm3 can help monitor prostate cancer in men who are already on active surveillance. It may help doctors decide if a biopsy is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult man 18 years or older.
- You have low-risk prostate cancer and are currently on active surveillance.
- You started active surveillance after January 1, 2022.
- You are scheduled for a follow-up prostate biopsy, either with a standard or MRI-targeted way.
- You have had a prostate MRI within the last three months.
- You have never had any treatment for prostate cancer like surgery, radiation, chemotherapy, or hormone therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new blood test (Stockholm3) helps predict prostate cancer findings on MRI. It enrolls men already scheduled for an MRI to screen for prostate cancer.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.